在有多期肝动脉期成像的HCC风险患者中,时间相位影响肝脏观察灶APHE亚型的一致性
该回顾性研究纳入141例HCC高危患者共238个肝脏观察灶,评估多期肝动脉期成像(mHAP)上动脉期高强化(APHE)亚型的一致性。87.8%(209/238)观察灶显示一致的非环状APHE,10.2%(24/238)显示一致的环状APHE,2.1%(5/238)显示不一致APHE亚型且均由非环状进展为环状。mHAP采集含门静脉期的时间相位影响APHE亚型一致性,排除门静脉期后无观察灶显示不一致APHE亚型。
要点
- mHAP成像上87.8%(209/238)观察灶显示一致的非环状APHE,10.2%(24/238)显示一致的环状APHE。
- 2.1%(5/238)观察灶APHE亚型不一致,均表现为非环状进展为环状。
- mHAP采集含门静脉期的时间相位影响APHE亚型一致性,评估APHE亚型时需先评估各期时间相位。
核心结论
- mHAP采集包含门静脉期的时间相位影响mHAP成像上肝脏观察灶APHE亚型的一致性;评估APHE亚型时有必要先评估mHAP技术所采集各期的时间相位。
研究设计与样本
- 回顾性研究,连续纳入2018年4月至2021年6月共141例HCC高危患者、238个肝脏观察灶,均行mHAP MRI采集;两名放射科医师独立评估各动脉期图像并按LI-RADS评估强化模式,另两名放射科医师独立识别并记录各期真实时间相位,分歧时由另一专家讨论决定。
关键影像表现/征象
- mHAP成像上87.8%(209/238)观察灶显示一致的非环状APHE。
- mHAP成像上10.2%(24/238)观察灶显示一致的环状APHE。
- 2.1%(5/238)观察灶APHE亚型不一致,均表现为非环状进展为环状。
- 87.9%(124/141)的mHAP采集均为动脉期,12.1%(17/141)的mHAP采集同时获得动脉期和门静脉期。
诊断标准与关键数值
- 两名放射科医师评估时间相位的一致性κ=0.712-0.887,评估APHE亚型的一致性κ=0.795-0.901。
- 单因素分析发现mHAP成像的时间相位影响肝脏观察灶APHE亚型的一致性。
- 排除mHAP成像采集的门静脉期后,无肝脏观察灶显示不一致的APHE亚型。
临床应用与阅片要点
- 评估肝脏观察灶APHE亚型时,应先评估mHAP技术所采集各期的时间相位。
- mHAP采集含门静脉期时,APHE亚型可能出现不一致,判读时需注意时间相位的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether liver observations in patients at risk for hepatocellular carcinoma (HCC) display inconsistent arterial phase hyperenhancement (APHE) subtypes on the multi-hepatic arterial phase imaging (mHAP) and to further investigate factors affecting inconsistent APHE subtype of observations on mHAP imaging.
METHODS: From April 2018 to June 2021, a total of 141 patients at high risk of HCC with 238 liver observations who underwent mHAP MRI acquisitions were consecutively included in this retrospective study. Two experienced radiologists reviewed individual arterial phase imaging independently and assessed the enhancement pattern of each liver observation according to LI-RADS. Another two experienced radiologists identified and recorded the genuine timing phase of each phase independently. When a disagreement appeared between the two radiologists, another expert participated in the discussion to get a final decision. A separate descriptive analysis was used for all observations scored APHE by the radiologists. The Kappa coefficient was used to determine the agreement between the two radiologists. Univariate analysis was performed to investigate the factors affecting inconsistent APHE subtype of liver observations on mHAP imaging.
RESULTS: The interobserver agreement was substantial to almost perfect agreement on the assessment of timing phase (κ = 0.712-0.887) and evaluation of APHE subtype (κ = 0.795-0.901). A total of 87.8% (209/238) of the observations showed consistent nonrim APHE and 10.2% (24/238) of the observations showed consistent rim APHE on mHAP imaging. A total of 2.1% (5/238) of the liver observations were considered inconsistent APHE subtypes, and all progressed nonrim to rim on mHAP imaging. 87.9% (124/141) of the mHAP acquisitions were all arterial phases and 12.1% (17/141) of the mHAP acquisitions obtained both the arterial phase and portal venous phase. Univariate analysis was performed and found that the timing phase of mHAP imaging affected the consistency of APHE subtype of liver observations. When considering the timing phase and excluding the portal venous phase acquired by mHAP imaging, none of the liver observations showed inconsistent APHE subtypes on mHAP imaging.
CONCLUSION: The timing phase which mHAP acquisition contained portal venous phase affected the inconsistency of APHE subtype of liver observations on mHAP imaging. When evaluating the APHE subtype of liver observations, it's necessary to assess the timing of each phase acquired by the mHAP technique at first.
引用
- Jiang J, Yang D, Yang Z, et al. The timing phase affected the inconsistency of APHE subtypes of liver observations in patients at risk for HCC on the multi-hepatic arterial phase imaging. Abdom Radiol (NY). 2024. PMID: 38195799. doi:10.1007/s00261-023-04096-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。